Successful treatment of macrophage activation syndrome complicating adult-onset Still’s disease with tocilizumab: a case report
Ho So, T. L. V. Wong, Hin Ting Pang, Weng Nga Lao, M.-L. Yip
Abstract
Ho So, T. L. V. Wong, Hin Ting Pang, Weng Nga Lao, M.-L. Yip
Abstract
Abstract We report a case of 50-year-old female patient with adult-onset Still’s disease (AOSD) complicated by macrophage-activation syndrome (MAS). After initial control of the disease with high-dose parenteral corticosteroids, tocilizumab (TCZ) therapy aided in maintaining the remission with rapid tapering of steroid dose. TCZ may be useful for MAS complicating AOSD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract We report a case of 50-year-old female patient with adult-onset Still’s disease (AOSD) complicated by macrophage-activation syndrome (MAS). After initial control of the disease with high-dose parenteral corticosteroids, tocilizumab (TCZ) therapy aided in maintaining the remission with rapid tapering of steroid dose. TCZ may be useful for MAS complicating AOSD.
Key concepts: Tocilizumab, Macrophage activation syndrome, Adult-onset Still's disease, Medicine, Disease, Internal medicine, Pediatrics, Immunology